June 10, 2014
Richmond, Va. (June 9, 2014) — HCA Virginia will be offering new 3D mammography - breast tomosynthesis for breast cancer screening – a new technology producing a three-dimensional view of the breast tissue that helps radiologists identify and characterize individual breast structures without the confusion of overlapping tissue.
"The purpose of obtaining this technology is to increase the accuracy of the mammograms by providing the additional 3D image to the traditional 2D mammogram, thereby enhancing the cancer detection rate at an early and thus more curable stage," said Esther Desimini, vice-president of oncology services, HCA Virginia. "We believe breast tomosynthesis will benefit all screening and diagnostic mammography patients, and is especially valuable for women receiving a baseline screening, those who have dense breast tissue and/or women with a personal history of breast cancer."
The tomosynthesis screening experience is similar to a traditional mammogram. During a tomosynthesis exam, multiple, low-dose images of the breast are acquired at different angles. These images are then used to produce a series of one-millimeter thick slices that can be viewed as a 3D reconstruction of the breast.
HCA Virginia will be using the Selenia® Dimensions® breast tomosynthesis system made by Hologic. The system offers exceptionally sharp breast images, an advanced ergonomic design providing more patient comfort, and the tomosynthesis platform designed to deliver screening and diagnostic performance for all breast types.
Desimini also says that breast cancer screening with tomosynthesis, when combined with a conventional 2D mammography has a 30 percent higher invasive cancer detection rate than conventional 2D mammography alone.
According to the American Cancer Society, breast cancer is the second leading cause of cancer death among women, exceeded only by lung cancer. Statistics indicate that one in eight women will develop breast cancer sometime in her lifetime. The stage at which breast cancer is detected influences a woman’s chance of survival. If detected early, the five-year survival rate is 98 percent. In addition, tomosynthesis can reduce the number of times patients need to return for additional testing and biopsies by 30 percent.
For more information, call HCA Virginia’s Cancer Care Network at 804.HCA.CARE (804.422.2273).
About HCA Virginia...As the commonwealth’s most comprehensive provider network, HCA Virginia Health System operates 13 hospitals and 30 outpatient centers and is affiliated with 3,000 physicians. It is one of Virginia’s largest employers, provides $365 million in uncompensated care and pays $72 million in state and local taxes each year. HCA Virginia includes 4 imaging centers, 6 outpatient surgery centers, one freestanding emergency room, and 7 hospitals – Chippenham, Henrico Doctors’, John Randolph, Johnston-Willis, Parham Doctors’, Retreat Doctors’ and Spotsylvania Regional.